April 5, 2025 - 05:49

The stock market is plunging. The US financial market spiraled after President Donald Trump imposed tariffs on Thursday, with fear and uncertainty being felt from Wall Street to Main Street. Analysts are expressing concern over the potential long-term impacts of these tariffs on the economy.
Many financial experts believe that the sudden increase in tariffs could lead to higher consumer prices and reduced spending power for American families. This, in turn, may stifle economic growth and lead to a slowdown in various sectors.
Investors reacted swiftly, causing significant declines in major stock indices. The uncertainty surrounding international trade relations has left many questioning the stability of the market. Experts warn that prolonged tariff disputes could escalate tensions with trading partners and disrupt supply chains, further exacerbating the situation.
As the market continues to react to these developments, the focus remains on the potential repercussions for both the economy and everyday consumers. The coming weeks will be critical in determining the trajectory of the financial landscape.
May 14, 2026 - 00:55
Aeluma Announces Third Quarter Fiscal 2026 Financial ResultsAeluma, Inc., a company specializing in compound semiconductor technologies, has released its financial results for the third quarter of fiscal year 2026. The report comes alongside several major...
May 13, 2026 - 11:31
MCK Q1 Deep Dive: Revenue Misses Analyst Expectations as Margin Initiatives ContinueHealthcare distributor McKesson reported first-quarter earnings that missed revenue expectations, though the company continued to push ahead with margin-focused initiatives. For the quarter ending...
May 12, 2026 - 23:07
Prudential Financial Declares Quarterly Dividend on Common StockNEWARK, N.J., May 12, 2026 -- Prudential Financial, Inc. has declared a quarterly dividend of $1.40 per share on its common stock. The payment is scheduled for June 11, 2026, and will go to...
May 12, 2026 - 03:06
Cellectis Reports First Quarter 2026 Financial ResultsCellectis has announced its financial results for the first quarter of 2026, alongside updates on its clinical pipeline and preclinical research programs. The company is advancing its pivotal...